ArticleCurrent therapeutic research, clinical and experimental2025

Safety and Efficacy of a Mesenchymal Stem Cell Secretome Therapy (KPI-012) for Persistent Corneal Epithelial Defects: A Phase 1b Trial.

Valeria Sánchez Huerta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.